About

About Top 10 Tirzepatide

Who we are, who publishes us, and how we hold our tirzepatide rankings to a consistent, disclosed standard.

Advertising disclosure: Top 10 Tirzepatide is a reader-supported editorial project from Generational Health™. Some provider links are affiliate links; if you sign up through one, we may earn a commission at no additional cost to you. Compensation never changes a provider's score — ratings follow our published methodology.

Who publishes this site

Top 10 Tirzepatide is an editorial site published by Generational Health, which is not owned by MaxLife. It is affiliate-supported: we earn referral commissions from providers we feature, including MaxLife, which currently ranks first on our published rubric. Because of that compensation, we do not describe this site as independent, unbiased, impartial, or third-party — it is not. What we can promise instead is transparency about that financial interest and a consistent, sourced method that we apply to every program, MaxLife included.

Why an affiliate-supported site can still be useful

A disclosed, affiliate-supported publication earns trust the honest way: by showing its work. We publish the exact rubric we score against, cite our sources, label every competitor figure with when it was sourced, and list MaxLife's real trade-offs alongside its strengths. We also refuse to overstate MaxLife's position — for example, we do not claim it is the only program with a clean regulatory record, because TrimRx also has no lawsuit or FDA warning letter on record as of June 2026. If our ranking cannot be justified by our stated method, we fix the method or the ranking, never the data.

Our editorial standards

  • Real, sourced data only. We do not invent prices, reviews, ratings, patients, or programs. Where we lack a confirmed value, we show a visible {{placeholder}} rather than guess.
  • Honest efficacy framing. Weight-loss figures are clinical-trial averages for the FDA-approved branded drugs, labeled as such, with the note that individual results vary and are not guaranteed.
  • Clear compounded status. Wherever we name a compounded medication, we state that compounded tirzepatide and semaglutide are not FDA-approved.
  • Real pros and cons. Every program, including MaxLife, gets its genuine downsides listed, not just its strengths.
  • No attack content. Where we note a competitor's legal or safety issue, it is factual, neutrally framed, and sourced — never a smear.

How our content is medically reviewed

Our tirzepatide content — the rankings, the dosing guide, and the comparison guides — is written to be reviewed by a licensed medical professional for clinical accuracy before publication. The reviewer's name and credential appear in the byline on every page. Until that reviewer is confirmed, the byline shows {{Medical Reviewer Name, Credential}} as a visible placeholder rather than a fabricated name. Medical review checks that dosing information matches the FDA-approved prescribing information for branded tirzepatide, that efficacy figures are cited correctly and framed as trial averages, and that nothing on the page reads as personalized medical advice.

This content is not medical advice

Everything on this site is for information only and is not medical advice. Tirzepatide is a prescription medication with real risks and contraindications. Talk with a licensed provider about whether it is appropriate for you before starting, changing, or stopping any treatment.

How we make money

Generational Health funds this site through referral commissions: when you enroll with a provider we feature, we may earn a commission — we disclose that plainly. Because of that financial interest, we do not present our rankings as impartial. Our aim is to be the most transparent tirzepatide resource in a category where transparency is scarce, and to let you compare MaxLife against real alternatives on the same criteria.

Corrections and contact

Program pricing and review counts change often. If you spot a figure that is out of date or believe we have gotten something wrong, we want to correct it. Contact details: {{Confirm contact email / corrections address}}.

Read our full methodology

Compounded medication notice: Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. They are prepared by U.S.-licensed compounding pharmacies when a licensed provider determines treatment is appropriate. Compounded semaglutide is not Ozempic® or Wegovy®; compounded tirzepatide is not Mounjaro® or Zepbound®. MaxLife is not affiliated with Novo Nordisk or Eli Lilly.